10x Genomics (TXG) Preferred Stock Liabilities (2018 - 2019)

10x Genomics (TXG) has 2 years of Preferred Stock Liabilities data on file, last reported at $243.2 million in Q2 2019.

• For the quarter ending Q2 2019, Preferred Stock Liabilities changed N/A year-over-year to $243.2 million; the trailing twelve-month figure through Jun 2019 stood at $243.2 million (changed N/A YoY), and the FY2018 full-year result was $243.2 million, up 53.55% from the prior year.
• Preferred Stock Liabilities steadied at $243.2 million in Q2 2019, from $243.2 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $243.2 million in Q4 2018 to a low of $208.3 million in Q3 2018.